Nano Letters Co-Editor Charles M. Lieber and Journal of the American Chemical Society (JACS) Associate Editor Benjamin F. Cravatt are among the newest members of the National Academy of Medicine (NAM). The health and medical community considers membership in NAM to be one of the field’s top honors. NAM membership recognizes individuals who have demonstrated outstanding professional achievement, commitment to service, and major contributions to the advancement of the medical sciences, health care, and public health.
Lieber is the Mark Hyman Professor of Chemistry, and the School of Engineering and Applied Sciences at Harvard University. He is known for his work in synthesizing a variety of nanoscale materials and devices for application in medicine. He’s also the recipient of the ACS Award in the Chemistry of Materials in 2004, and the 1992 ACS Award in Pure Chemistry.
Cravatt is a Professor and Co-Chair of the Department of Molecular Medicine at The Scripps Research Institute. His research group is interested in understanding the roles that enzymes play in physiological and pathological processes, especially as it pertains to the nervous system and cancer. Cravatt is also an Editorial Advisory Board Member of Biochemistry and ACS Chemical Biology. He is the recipient of the 2004 Eli Lilly Award in Biological Chemistry and the 2017 ACS Chemical Biology Lectureship Award.
Lieber and Cravatt are among the 70 regular members and 10 international members elected during NAM’s annual meeting. NAM rules require that at least one quarter of the organization’s total membership come from outside the health professions. NAM now has 2,127 members, along with 172 international members. NAM membership carries with it a commitment to volunteer service to National Academies activities.
NAM was created in 1970 by the National Academy of Sciences as the Institute of Medicine. NAM, along with the National Academy of Sciences and the National Academy of Engineering, provides independent, objective analysis, and advice to the nation on public policy decisions.